Fracture status in middle-aged individuals with early CKD: cross-sectional analysis of the CARTaGENE survey.


Journal

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
ISSN: 1433-2965
Titre abrégé: Osteoporos Int
Pays: England
ID NLM: 9100105

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 02 11 2018
accepted: 12 02 2019
pubmed: 24 2 2019
medline: 18 12 2019
entrez: 24 2 2019
Statut: ppublish

Résumé

Whether early chronic kidney disease (CKD) is associated with fracture in middle-aged adults is unclear. In a cross-sectional analysis of the CARTaGENE survey, we observed that early CKD was not associated with increased fracture, did not modify the association between calcaneal QUS and fracture, but modified the association between clinical, pharmacological parameters and fracture. The association between advanced CKD and increased fracture risk is well described. However, whether early CKD is associated with increased fractures, especially in middle-aged adults, is unclear. We aimed to assess if early CKD is associated with increased fracture status and whether early CKD status modifies the association between calcaneal quantitative ultrasound parameters, clinical, pharmacological parameters, and fractures. Cross-sectional analysis of CARTaGENE, a population-based survey of 40- to 69-year-old individuals. Individuals with CKD (stage 2, estimated glomerular filtration rate [eGFR] 60-89 ml/min/1.73 m A total of 17,608 individuals (656 CKD stage 3; 8227 stage 2; 8725 non-CKD) were included. CKD stage 2 and 3 individuals (mean eGFR 78 and 53 ml/min/1.73 m CKD stage 3 was not associated with an increase in fracture status. QUS parameters were similarly associated with fracture status in patients with and without CKD.

Identifiants

pubmed: 30796539
doi: 10.1007/s00198-019-04902-1
pii: 10.1007/s00198-019-04902-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

787-795

Subventions

Organisme : Fonds de Recherche du Qu?bec - Sant?
ID : 32661
Organisme : Kidney Foundation of Canada
ID : KFOC160013

Références

Kidney Int. 2000 Jul;58(1):396-9
pubmed: 10886587
Kidney Int. 2000 Nov;58(5):2200-5
pubmed: 11044242
Am J Kidney Dis. 2000 Dec;36(6):1115-21
pubmed: 11096034
JAMA. 2003 Oct 1;290(13):1729-38
pubmed: 14519707
Kidney Int. 2006 Jun;69(11):1945-53
pubmed: 16641930
J Am Soc Nephrol. 2006 Nov;17(11):3223-32
pubmed: 17005938
J Am Soc Nephrol. 2007 Jan;18(1):282-6
pubmed: 17167115
Nephrol Dial Transplant. 2007 Apr;22(4):1171-6
pubmed: 17205962
Nephrol Dial Transplant. 2008 Feb;23(2):586-93
pubmed: 17933842
Am J Kidney Dis. 2008 Jan;51(1):38-44
pubmed: 18155531
J Am Geriatr Soc. 2008 Aug;56(8):1434-41
pubmed: 18662213
Calcif Tissue Int. 1991 Aug;49(2):107-11
pubmed: 1913288
Epidemiology. 1991 Mar;2(2):116-22
pubmed: 1932308
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
Geriatr Gerontol Int. 2009 Sep;9(3):246-52
pubmed: 19702934
JAMA. 2009 Oct 21;302(15):1666-73
pubmed: 19843901
Bone. 2011 May 1;48(5):1127-32
pubmed: 21281749
Osteoporos Int. 2012 Jan;23(1):143-53
pubmed: 22037972
Geriatr Gerontol Int. 2012 Apr;12(2):330-5
pubmed: 22122503
Int J Epidemiol. 2013 Oct;42(5):1285-99
pubmed: 23071140
Joint Bone Spine. 2012 Dec;79(6):544-9
pubmed: 23177912
Clin J Am Soc Nephrol. 2013 Aug;8(8):1367-76
pubmed: 23660179
Osteoporos Int. 2014 Jan;25(1):159-65
pubmed: 23835863
Am J Kidney Dis. 2014 Jan;63(1):31-9
pubmed: 23890927
Osteoporos Int. 2014 Jan;25(1):105-20
pubmed: 24013517
Kidney Int. 2014 Oct;86(4):810-8
pubmed: 24429401
Clin J Am Soc Nephrol. 2014 Apr;9(4):713-9
pubmed: 24458079
J Bone Miner Res. 2015 May;30(5):913-9
pubmed: 25400209
Osteoporos Int. 2015 Feb;26(2):449-58
pubmed: 25477230
Osteoporos Int. 2015 May;26(5):1459-75
pubmed: 25634771
Clin J Am Soc Nephrol. 2015 Apr 7;10(4):646-53
pubmed: 25655423
Osteoporos Int. 2015 Jul;26(7):1979-87
pubmed: 25690339
PLoS One. 2015 Apr 13;10(4):e0121705
pubmed: 25874794
J Hypertens. 2015 Apr;33(4):727-35; discussion 735
pubmed: 25915877
J Clin Densitom. 2015 Apr-Jun;18(2):157-64
pubmed: 25937306
Am J Kidney Dis. 2016 Feb;67(2):218-226
pubmed: 26250781
Menopause. 2016 Apr;23(4):461-70
pubmed: 26529613
Kidney Int. 2016 Feb;89(2):289-302
pubmed: 26806832
J Bone Miner Res. 2016 Oct;31(10):1803-1809
pubmed: 27145189
Nephrol Dial Transplant. 2017 Jun 1;32(6):976-983
pubmed: 27190343
Kidney Int. 2017 Jul;92(1):26-36
pubmed: 28646995
JAMA. 2017 Dec 26;318(24):2466-2482
pubmed: 29279934
JAMA. 2018 Apr 17;319(15):1600-1612
pubmed: 29677308
Osteoporos Int. 2018 Sep;29(9):2129-2138
pubmed: 29947873

Auteurs

L-C Desbiens (LC)

CHU de Québec Research Center, L'Hôtel-Dieu-de-Québec Hospital, Endocrinology and Nephrology Axis, Faculty and Department of Medicine, Université Laval, 10 McMahon, Quebec City, Quebec, G1R 2J6, Canada.

R Goupil (R)

Nephrology Division, Hôpital du Sacré-Coeur de Montréal, Montreal, CA, Canada.

A Sidibé (A)

CHU de Québec Research Center, L'Hôtel-Dieu-de-Québec Hospital, Endocrinology and Nephrology Axis, Faculty and Department of Medicine, Université Laval, 10 McMahon, Quebec City, Quebec, G1R 2J6, Canada.

F Madore (F)

Nephrology Division, Hôpital du Sacré-Coeur de Montréal, Montreal, CA, Canada.

F Mac-Way (F)

CHU de Québec Research Center, L'Hôtel-Dieu-de-Québec Hospital, Endocrinology and Nephrology Axis, Faculty and Department of Medicine, Université Laval, 10 McMahon, Quebec City, Quebec, G1R 2J6, Canada. fabrice.mac-way@mail.chuq.qc.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH